Emergent BioSolutions scores nod for longer-lasting opioid overdose drug

The new product comes about five years after the FDA approved its original Narcan nasal spray.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.